Schedule 13G ownership disclosure

AUTONOMIX MED INC

Common Stock, $0.001 par value per share · CUSIP: 05330T205

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BioStar Ventures III, L.P.

    Shares: 175,216.00 · Class: 4.3%

  • BioStar Ventures III, L.L.C.

    Shares: 175,216.00 · Class: 4.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-021893
Form type
SCHEDULE 13G/A
Filer
Autonomix Medical, Inc.
CIK
CIK 1617867
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub